vascular structures, especially the lower cranial nerves, rendering the tumor difficult to resect completely.
Postoperative Course. Postoperatively, the patient showed no abnormal neurological findings except for dizziness. Postsurgical brain MRI showed a small remnant tumor along the lower cranial nerves (Fig. 3 ). Histopathological findings indicated an adamantinomatous CPG (Fig. 4) .
Workup for Gardner's Syndrome. We reviewed case reports describing instances of primary ectopic CPG. We identified multiple osteomas in the patient's skull on brain CT (Fig. 5) . We suspected Gardner's syndrome given the multiple osteomas. We performed colonoscopy and gastroduodenoscopy for diagnosing FAP. Colonoscopy demonstrated multiple polyps but fewer than 100 (Fig. 6) . Biopsy of 1 rectal polyp identified villotubular adenoma with high-grade atypia associated with intraepithelial adenocarcinoma. Gastroduodenoscopy showed more than 100 polyps (Fig. 7) . Biopsy of 1 stomach polyp demonstrated fundic gland polyposis. Computed tomography scanning of the patient's jaw revealed dental anomalies, and a panoramic view demonstrated 1 osteoma located in the right mandibular angle (Fig. 8) . Abdominal CT scanning demonstrated bilateral adrenal adenomas (Fig. 9) . Congenital hypertrophy of the retinal pigment epithelium was not found on fundoscopy or retinal CT scans. No abnormal skin lesion was identified.
Gene Study. The germline status of the APC gene on chromosome 5q22, which is mutated in individuals with FAP, was identified in peripheral blood leukocyte DNA. The APC gene was analyzed via polymerase chain reaction and direct sequencing of the entire exon and intron region of the APC gene using an ABI genetic analyzer (3500xL, Life Technologies). A truncating frameshift mutation in the APC gene was detected in the 16th exon (c.4541_4547delCATTTATinsTTTCC coded according to the reference sequence at http://www.ncbi.nlm.nih. gov/nuccore/NM_000038). This resulted in a frameshift change with proline-1514 as the first affected amino acid, replacing it with a leucine and creating a new reading frame ending in a stop at the position of the 18th codon. Follow-Up. We recommended radiosurgery for the residual CPG and total removal of the colon and rectum with preservation of the anus, but the patient refused further treatment because of economic and medical insurance problems. He showed no additional neurological defi cit after 3 months.
Discussion

Familial Adenomatous Polyposis and Gardner's Syndrome
Familial adenomatous polyposis is an autosomal dominant disorder resulting from a mutation of the APC tumor suppressor gene residing at position 21-22 on the long arm of chromosome 5.
2,13 Different families with FAP can have different mutations of the APC gene, but all mutations are in stop codons and result in truncation of the APC protein. 11 It is clinically diagnosed in individuals with more than 100 colorectal adenomatous polyps or in those with fewer than 100 polyps and a first-degree relative with FAP. 1 In our patient, we identified an APC gene mutation, more than 100 gastroduodenal polyps, and fewer than 100 colorectal polyps. We think that he may have had FAP; however, we could not identify a family history for FAP, and the patient had fewer than 100 colorectal polyps. Therefore, we could not confirm FAP, although we think that he will develop more than 100 polyps in the colon, which would confirm FAP. Gardner's syndrome is a variant of FAP with the same mutation of the APC gene. 16 It is an autosomal dominant form of polyposis characterized by the presence of multiple polyps in the colon together with tumors outside the colon. Gardner's syndrome is associated with characteristic multiple craniomaxillofacial osteomas, dental anomalies, skin and soft-tissue tumors, and congenital hypertrophy of the retinal pigment epithelium. 3 Other common extracolonic manifestations of Gardner's syndrome include osteomas of the long bone, fibromas, leiomyomas, lipomas, mesenteric desmoid tumors, periampullary and duodenal carcinomas, hepatoblastomas, benign and malignant biliary and adrenal neoplasms, and papillary carcinomas of the thyroid. In our patient, we identified dental anomalies, multiple skull osteomas, 1 osteoma of the mandible, and bilateral adrenal adenomas. Although he did not satisfy the strict criteria for FAP, we think that he may have had Gardner's syndrome.
Craniopharyngioma Development in Patients With FAP
Whether the origin of the CPG in our patient was the result of a genetic predisposition or purely coincidental could not be elucidated. Despite the association suggested by 4 cases, including the present one, little direct evidence of a link between FAP and CPG has been found. 12, 16 Two clinicopathological variants of CPG have been identified:
6,17,21 the adult papillary squamous type and the classic childhood adamantinomatous variant. Adamantinomatous CPGs are the more commonly encountered subtype, and although seen predominantly in the pediatric population, they can present at any age. Histologically, they contain nodules of wet keratin, a palisading basal layer of cells, intense surrounding gliosis, and profuse Rosenthal fiber formation.
8 All 3 CPGs previously associated with Gardner's syndrome were of the adamantinomatous type.
The molecular pathogenesis of CPG has not been extensively investigated. The mutations of genes encoding b-catenin (CTNNB1 and APC) are an exclusive characteristic of adamantinomatous CPG and may play a role in CPG initiation and growth. 9, 14, 19 Mutations in bcatenin encoding genes and overexpression of b-catenin are considered to be characteristics of adamantinomatous CPGs. All mutations affect exon 3, which encodes the degradation targeting box of b-catenin, consistent with an accumulation of nuclear b-catenin. 4 In the absence of Wnt, the intracellular proteins axin, APC, and glycogen synthase kinase-3b (GSK-3b) form a stable complex, which functions to phosphorylate and degrade b-catenin. However, when Wnt is bound to the cell-surface receptor complex composed of fizzled and low-density lipoprotein receptor-related protein, the phosphorylation of b-catenin is prevented. The subsequent unphosphorylated form of b-catenin is protected from axin/APC/GSK-3b-mediated protease degradation and is therefore accumulated within the cytoplasm and nucleus. 8 In adamantinomatous CPG, all genetic alterations targeted only the GSK-3b phosphorylation site of the b-catenin encoding gene. 4 Therefore, mutation of b-catenin seems to play an important role in the etiology of an adamantinomatous CPG. 19 In contrast to Wnt/b-catenin-mediated tumorigenesis in other cancers, mutations in APC and axin have not been described in CPG. 4 Interestingly, CPG cells with- out mutations in the CTNNB1 gene can overexpress bcatenin, 5 implying alternative mechanisms of b-catenin nuclear accumulation that may be relevant to tumor development.
Familial adenomatous polyposis results from mutations in the APC gene, which encodes a negative regulator of the Wnt pathway. Patients with FAP can develop Wnt pathway-associated neoplasms such as desmoid tumors. 15 Germline mutations affecting the APC gene are the underlying cause of FAP, and somatic mutations in those regions of the APC gene, known to compromise the ability of APC to interact with b-catenin, can be detected in the majority of sporadic colorectal cancers. 18 Nuclear accumulation of b-catenin derives also from loss-of-function mutations of the APC gene within a clustered region corresponding to the b-catenin/axin binding domain. 4 The APC mutations almost always cause loss of the C-terminal functions of the APC protein-probably involved in microtubule binding, cell polarity, and chromosome segregation-and deletion of the serine-alanine-methionineproline repeats that are important for binding to axin and formation of the b-catenin phosphorylation complex. 18 We think that the origin of adamantinomatous CPG in our patient may have been a phenotypic result of APC gene mutation, and this occurrence is not coincidental. However, not all patients with FAP present with CPG. We think that the development of CPG depends on further somatic genetic events, each of which may be under different influences and selection pressures.
